Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 7th Targeted Radiopharmaceuticals Summit Europe.

Alex Castellarnau

Development Manager

Starpharma Ltd.

Alyssa Vito

Senior Director, Clinical Development

Alpha-9 Oncology

Andreas Goutopoulos, CEO, ActiThera

Andreas Goutopoulos

CEO

ActiThera

Angeliki Grammenos, Global Regulatory Affairs Associate Project Lead, Debiopharm

Angeliki Grammenos

Global Regulatory Affairs Associate Project Lead

Debiopharm

Anil Lalwani, Director - Regulatory Chemistry, Manufacturing Controls & MedTech, Telix Pharmaceuticals

Anil Lalwani

Director - Regulatory Chemistry, Manufacturing, Controls & MedTech

Telix Pharmaceuticals

Arthur Braat, Associate Professor, UMC Utrecht

Arthur Braat

Associate professor 'Translational Nuclear Oncology', Nuclear Medicine Physician

UMC Utrecht

Bala Atilli, Director - Oncology Safety Sciences, AstraZeneca

Bala Nn Rao Attili

Director - Oncology Safety Sciences

AstraZeneca

Catello Somma, Partner, Seroba Life Sciences

Catello Somma

Partner

Seroba Life Sciences

Daniel Rossetto, Senior Vice President, Head Of Supply Chain & External Manufacturing, ARTBIO

Daniel Rossetto

Head Senior VP, Supply Chain & External Manufacturing

ARTBIO

Daniel Steiner, Senior Vice President - Oncology Research, Molecular Partners AG

Daniel Steiner

Senior Vice President - Oncology Research

Molecular Partners AG

Fredrik Frejd, CSO Affibody A

Fredrik Frejd

Chief Scientific Officer

Affibody AB

George Loudos

Chief Vision Officer

BIOEMTECH Laboratories

Guido Wuerth, Head Corporate Development, Radiopharma, Affibody AB

Guido Würth

dfd

Affibody AB

Hadis Westin

Director - Scientific Marketing

Ridgeview Instruments AB

Harshad Kulkarni, Chief Medical Advisor, Bamf Health

Harshad Kulkarni

Chief Medical Advisor

Bamf Health

Isabel Jaco, Senior Principal Scientist & Group leader - Radioligand Therapy Drug Discovery, Novartis AG

Isabel Jaco

Senior Principal Scientist, Group leader - Radioligand Therapy Drug Discovery

Novartis AG

Jarrod Longcor, Chief Operating Officer, Cellectar Biosciences Inc.

Jarrod Longcor

Chief Operating Officer

Cellectar Biosciences Inc.

Jeff Cleland, Co-Founder, Iron Fist Therapeutics

Jeff Cleland

Co-Founder

Iron Fist Therapeutics

Jeremy Paull, Chief Scientific & Regulatory Officer, Starpharma Ltd

Jeremy Paull

Chief Scientific & Regulatory Officer

Starpharma Ltd.

John Babich, President & Chief Scientific Officer, Ratio Therapeutics

John babich

President & Chief Scientific Officer

Ratio Therapeutics, Inc.

Josefine Reber, Lab Head, Molecular Imaging & RLT, Novartis AG

Josefine Reber

Lab Head, Molecular Imaging & RLT

Novartis AG

Josie Gayton, Chief Operating Officer, Precirix

Josie Gayton

Chief Operating Officer

Precirix

Julia Jauch-Lembach

Executive Medical Director

Debiopharm

Julie Nonnekens

Associate Professor, Radiobiology of Radionuclide Therapy

Erasmus MC Cancer Institute

Kemp Dolliver, Senior Director - Research Analyst, Brookline Capital Markets

Kemp Dolliver

Senior Director - Research Analyst

Brookline Capital Markets

Larissa van Golen, Nuclear Medicine Phsyicist, The Netherlands Cancer Institute

Larissa van Golen

Nuclear Medicine Phsyicist

The Netherlands Cancer Institute

Levete Meszaros, Head, Clinical Operations & Programs, RadioPharm Theranostics

Levente Meszaros

Vice President - Preclinical & Translational Science

RadioPharm Theranostics

Lucy Knight

Director - Project Management

PSI CRO

Luke Brzozowski, Executive Director, Theranostics and Core Facilities, University Health Network

Luke Brzozowski

Exec Dir. Theranostics

University Health Network

Manuel Sturzbecher Hohne, Head of CMC & Radiopharmaceutical Development, Ariceum Therapeutics

Manuel Sturzbecher-Hoehne

Head of CMC & Radiopharmaceutical Development

Ariceum Therapeutics

Mark Fielding

Director - Chemistry, Manufacturing & Controls Regulatory Affairs Radiopharmaceuticals

AstraZeneca

Michael Hamm

Head of Business Development

Navigo Proteins GmbH

Michael Thiele, Chief Scientific Officer, OncoOne

Michael Thiele

Chief Scientific Officer

OncoOne

Munir Ghesani

Chief Medical Officer

United Theranostics

Nicoletta Fabiano, Head of RLT Analytical Development Team, Novartis AG

Nicoletta Fabiano

Rlt Analytical Development Team Head

Novartis AG

Oystein Soug, Chief Executive Officer, OncoOne

Puste Soug

Ceo

Oncoinvent

Rebecca Ferrisi, Postdoctoral Researcher, University of Milan

Rebecca Ferirsi

Postdoctoral Researcher

University of Milan

Sandra Hennig, RA CMC Strategist, Bayer

Sandra Hennig

RA CMC Strategist

Bayer

Setareh Shamsili, Chief Executive Officer & Chief Marketing Officer, Coretag

Setareh Shamsili

Chief Executive Officer & Chief Marketing Officer

Coretag

Shaemus Gleason, Executive Vice President, Clarity Pharmaceuticals

Shaemus gleason

RVP

Clarity Pharmaceuticals

Sigal Kalmanson Cusnir

Chief Executive Officer and Co-Founder

Starget Pharma

Siva Genapathy

Assoc. Director

Bicycle Therapeutics plc

Stephen Archibald, Head, Research Department of Imaging Chemistry & Biology, Kings College London

Stephen Archibald

Head, Research Department of Imaging Chemistry & Biology

Kings College London

Stuart More, Head of Department - Nuclear Medicine, University of Cape Town

Stuart More

Lecturer & Senior Lecturer

University of Cape Town

Thijs Spoor, Chief Executive Officer, Perspective Therapeutics

Thijs Spoor

Chief Executive Officer

Perspective Therapeutics, Inc.

Thom Tulip

Chief Business Officer

Cerveau Technologies

Thomas Birger Eden-Jensen, Head of External Supply Management & Radiopharmaceuticals, Bayer

Thomas Birger Edén-Jensen

External Supply Management Radiopharmaceuticals Head (Esm)

Bayer

Tim Witney, Chief Scientific Officer, Nuclide Therapeutics

Tim Witney

Chief Scientific Officer

Nuclide Therapeutics

Vimal Patel, Vice President - Chemistry, Manufacturing & Controls, RadioPharm Theranostics

Vimal Patel

Director, Management Consulting

RadioPharm Theranostics

Volker Wagner, Chief Medical Officer, OranoMed

Volker Wagner

Chief Medical Officer

OranoMed

Yushuke Kohno, Head of Supply Chain Development, Alpha Fusion Inc.

Yusuke Kohno

Head of Supply Chain Development

Alpha Fusion Inc.

Conference Image
Explore the Agenda

Explore the latest industry breakthroughs and get exclusive insights into radiopharmaceutical innovations with our expanded three-track agenda, covering discovery, preclinical research, translational science, clinical progress, CMC, and supply chain strategies.

View Presentations & Speakers
Conference Image
Partner With Us

Align yourself with other leading solution providers to ensure your brand remains central to key biopharma deals and decision-making.

Explore Sponsorship Options
Conference Image
Join Biopharma Experts

Join the most important conversations with like-minded professionals across all stages of drug development, and build critical connections during dedicated networking sessions designed to foster collaboration and harmonisation throughout the entire development journey.

Register Now